Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ExBRAC - Expressive Writing in Breast Cancer - The Pilot Study

NCT06230068 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT06230068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06230068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ExBRAC - Expressive Writing in Breast Cancer - The Pilot Study
Lead sponsor
Region Skane
Phase
Not applicable
Overall status
Completed
Start date
March 26, 2024
Completion date
March 1, 2025
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, quality of life